CAS 18323-43-8

L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-4-ethyl-1-methyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-

CAS : 18323-43-8

Formule : C₁₇H₃₁ClN₂O₅S

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 410.9564

Ref: IN-DA0027FM

Clindamycin EP Impurity B

CAS : 18323-43-8

Formule : C₁₇H₃₁ClN₂O₅S

Couleur et forme : Pale Yellow Solid

Masse moléculaire : 410.95

Ref: 4Z-C-505

Clindamycin B

Produit contrôlé

CAS : 18323-43-8

Impurity Clindamycin HCl EP Impurity B
Applications Clindamycin B (Clindamycin HCl EP Impurity B) is a minor impurity of Clindamycin (C580000) in bulk drug.
References Duckworth, C., et al.: J. Antimicrob. Agents Chemother., 31, 581(1993), Orwa, J., et al.: J. Pharm. Biomed. Anal., 23, 771 (2000), Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006),

Formule : C₁₇H₃₁ClN₂O₅S

Couleur et forme : Neat

Masse moléculaire : 410.96

Ref: TR-C580040

Clindamycin B-d3

Produit contrôlé

CAS : 18323-43-8

Formule : C₁₇D₃H₂₈ClN₂O₅S

Couleur et forme : Neat

Masse moléculaire : 413.975

Ref: TR-C580042

Clindamycin B

CAS : 18323-43-8

Clindamycin B is an antibiotic that belongs to the group of lincosamides. It is a pyrimidine compound that inhibits the production of inflammatory cytokines such as IL-1, IL-6, and TNF-α by inhibiting matrix metalloproteinase activity. Clindamycin B also binds to the receptor binding site on the interleukin-1 receptor, which prevents it from interacting with the interleukin-1 receptor. This drug has been used clinically for treating inflammatory diseases and cancer.

Degré de pureté : Min. 95%

Ref: 3D-FC180575

Clindamycin Impurity B

CAS : 18323-43-8

Formule : C₁₇H₃₁ClN₂O₅S

Masse moléculaire : 411

Ref: ST-EA-CP-C26052